News

Filter

Current filters:

APP Pharmaceuticals

1 to 9 of 11 results

Generic launches of irinotecan, Primaxin and Merrem

08-02-2012

Japan’s ASKA Pharmaceuticals has announced the launch of irinotecan, the active ingredient of Campto…

ActavisAntibiotics and Infectious diseasesAPP PharmaceuticalsASKA PharmaceuticalsFresenius KabiGenericsirinotecanMarkets & MarketingMerrem I.V.Oncology

The Medicines Co settles with APP over Angiomax

24-01-2012

The Medicines Company (Nasdaq: MDCO) says that it has settled the law suits filed by company in the US…

AngiomaxAPP PharmaceuticalsCardio-vascularFresenius KabiGenericsLegalNorth AmericaPatentsPharmaceuticalThe Medicines Company

APP debuts generic Zemuron in USA

26-01-2009

APP Pharmaceuticals, a US manufacturer of multi-source and branded injectable pharmaceutical products,…

Amino AcidsAPP PharmaceuticalsInjectionOrganonPhysostigmine SalicylateRocuronium Bromide InjectionZemuron

New division Fresenius Kabi reports first results

17-11-2008

Fresenius Kabi Pharmaceuticals, the new holding company formed when German dialysis and home medical…

APP Pharmaceuticals

APP Puerto Rico heparin facility cleared by FDA

01-09-2008

USA-based APP Pharmaceuticals, a provider of hospital-based injectable pharmaceutical products, says…

Amino AcidsAPP PharmaceuticalsAzithromycinBenadrylDiphenhydramineDoxycyclineheparinInjectionMonodoxOraceaPhysostigmine SalicylateZithromaxZithromax InjectionZmax

Germany's Fresenius to buy US injectables group APP for up to $4.6 billion

14-07-2008

German dialysis and home medical care specialist Fresenius has entered into a definitive merger agreement…

APP Pharmaceuticals

APP's 4th-qtr net profit falls 70% after spinout

24-03-2008

USA-based APP Pharmaceuticals says that its fourth quarter profit, which fell 70% to $8.5 million, was…

AbraxisAPP PharmaceuticalsBaxterBaxter Biopharma SolutionsBaxter Healthcare Corporation's BioPharma SolBaxter Internationalheparin

1 to 9 of 11 results

Back to top